Urgent Revascularization
Showing 1 - 25 of 2,812
Diabetes, Acute Coronary Syndrome, Coronary Artery Disease Trial in Paris (Novel strategy Aspirin, Conventional strategy
Active, not recruiting
- Diabetes Mellitus
- +3 more
- Novel strategy Aspirin
- Conventional strategy Aspirin
-
Paris, FranceDepartment of Cardiology - Lariboisiere Hospital
Jan 2, 2023
Simultaneous Cardiac Surgery and Micronet-covered Stent Carotid
Recruiting
- Carotid Stenosis
- +4 more
- Simutaneous (single anaesthesia) carotid artery stenting with MicroNet covered stent (CGuard) and cardiac surgery (CABG or surgical valve replacement / repair procedure)
-
Krakow, PolandDepartment of Cardiac and Vascular Diseases, John Paul II Hospit
Jul 13, 2021
Restenosis After Lower Extremity Endovascular Revascularization
Recruiting
- Peripheral Artery Disease
-
Rome, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS
Feb 25, 2023
Arteriosclerosis, Hypercholesterolaemia Trial (MK-0616, Placebo)
Not yet recruiting
- Arteriosclerosis
- Hypercholesterolaemia
- MK-0616
- Placebo
- (no location specified)
Aug 17, 2023
Coronary Artery Disease, Aortic Valve Stenosis, TAVI Trial in Worldwide (PCI)
Active, not recruiting
- Coronary Artery Disease
- +3 more
- PCI
-
Aalborg, Denmark
- +11 more
Nov 8, 2022
Myocardial Infarction, Cardiovascular Disease Trial in Worldwide (Cardiovascular Polypill, Treatment Prevention for Secondary
Completed
- Myocardial Infarction
- Cardiovascular Disease
- Cardiovascular Polypill
- Treatment Prevention for Secondary CV
-
Praha, Praha 10, Czechia
- +112 more
Jun 28, 2022
Atherosclerotic Cardiovascular Disease Trial in Worldwide (Placebo, Olpasiran)
Recruiting
- Atherosclerotic Cardiovascular Disease
- Placebo
- Olpasiran
-
Huntsville, Alabama
- +83 more
Feb 1, 2023
Primary Prevention of Atherosclerotic Cardiovascular Disease Trial (Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran)
Not yet recruiting
- Primary Prevention of Atherosclerotic Cardiovascular Disease
- Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL
- Placebo in 1.5ml
- (no location specified)
Feb 13, 2023
Myocardial Infarction Trial in Bologna, Ferrara, Reggio Emilia (Angiography-guided PCI, Angiography-derived FFR PCI indication
Not yet recruiting
- Myocardial Infarction
- Angiography-guided PCI
- Angiography-derived FFR PCI indication and planning
-
Bologna, BO, Italy
- +2 more
Apr 5, 2023
Coronary Artery Disease, Heart Failure Systolic Trial (Revascularization by PCI, Revascularization by CABG)
Not yet recruiting
- Coronary Artery Disease
- Heart Failure Systolic
- Revascularization by PCI
- Revascularization by CABG
- (no location specified)
Jul 13, 2022
Stable Ischemic Heart Disease, Coronary Artery Disease, Beta-blocker Therapy Trial in Edmonton (Medical Assessment, Quality of
Recruiting
- Stable Ischemic Heart Disease
- +2 more
- Medical Assessment
- Quality of Life Assessment
-
Edmonton, Alberta, CanadaUniversity of Alberta Hospital
Jan 30, 2023
Coronary Atherosclerosis Due to Calcified Coronary Lesion Trial (Non-invasive stress test, Medical treatment without further
Not yet recruiting
- Coronary Atherosclerosis Due to Calcified Coronary Lesion
- Non-invasive stress test
- Medical treatment without further testing
- (no location specified)
Mar 21, 2023
ST-elevation Myocardial Infarction, Thrombus, Stents Trial in Naples (MGuard net protective coronary stent, Bare-metal stent and
Completed
- ST-elevation Myocardial Infarction
- +2 more
- MGuard net protective coronary stent
- Bare-metal stent and manual thrombectomy device
-
Naples, ItalyFederico II University of Naples
Mar 15, 2022
Xience Skypoint Stents in Routine Clinical Practice
Not yet recruiting
- Coronary Artery Disease
- XIENCE Skypoint™ stent
-
Seoul, Korea, Republic ofAsan Medical Hospital
Aug 1, 2023
Ischemic Heart Disease Trial in New York (Revascularization by Coronary Artery Bypass Graft or Percutaneous Coronary
Recruiting
- Ischemic Heart Disease
- Revascularization by Coronary Artery Bypass Graft or Percutaneous Coronary Intervention
-
New York, New YorkGramercy Cardiac Diagnostic Services
Aug 17, 2021
Hybrid Coronary Revascularization
Recruiting
- Percutaneous Coronary Revascularization
- +3 more
- Hybrid Coronary Revascularization
-
Seoul, Korea, Republic ofAsan Medical Center
Jun 30, 2022
Coronary Artery Disease, Plaque, Atherosclerotic Trial in Worldwide (Coronary intervention, Optimal Medical treatment)
Active, not recruiting
- Coronary Artery Disease
- Plaque, Atherosclerotic
- Coronary intervention
- Optimal Medical treatment
-
New York, New York
- +17 more
Nov 1, 2021
IRIS- DESyne X2 in the IRIS-DES Registry
Recruiting
- Coronary Stenosis
- +2 more
- DESyne X2
-
Incheon, Korea, Republic of
- +5 more
Dec 11, 2022
Rotational Atherectomy in Routine Clinical Practice
Recruiting
- Atherosclerosis, Coronary
- Coronary Stenosis
- Rotational atherectomy
-
Bucheon, Korea, Republic of
- +7 more
Dec 12, 2022
Vascular Access Complication, Radial Artery, Coronary Artery Disease Trial in Chojnice (distal radial artery acess side,
Completed
- Vascular Access Complication
- +4 more
- distal radial artery acess side
- conventional radial artery acess side
-
Chojnice, Pomeranian, PolandSzpital Specjalistyczny
Aug 1, 2023
Myocardial Ischemia, Acute Coronary Syndrome Trial (Eptifibatide (Integrilin), Placebo)
Completed
- Myocardial Ischemia
- Acute Coronary Syndrome
- Eptifibatide (Integrilin)
- Placebo
- (no location specified)
Feb 7, 2022
Orsiro™ Drug Eluting Stent in Routine Clinical Practice
Active, not recruiting
- Angioplasty, Transluminal, Percutaneous Coronary
- Coronary Artery Disease
- Orsiro™ Drug Eluting Stent group
-
Anyang, Korea, Republic of
- +17 more
Dec 11, 2022
Vascular Diseases, Peripheral Artery Disease, Surgery Trial (neuraxial anesthesia)
Not yet recruiting
- Vascular Diseases
- +2 more
- neuraxial anesthesia
- (no location specified)
Sep 27, 2023
Percutaneous Transluminal Coronary Angioplasty, Coronary Artery Disease Trial in Korea, Republic of (XIENCE
Active, not recruiting
- Percutaneous Transluminal Coronary Angioplasty
- Coronary Artery Disease
- XIENCE Xpedition/Alpine/Sierra
-
Anyang, Korea, Republic of
- +25 more
Dec 12, 2022
Personalized Antiplatelet Therapy in CAD Patients
Completed
- Coronary Artery Disease
- (no location specified)
Dec 14, 2021